4.6 Article

Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 294, Issue 33, Pages 12359-12369

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.RA119.007409

Keywords

alcohol; inflammasome; macrophage; autophagy; chemokine; Toll-like receptor 4 (TLR4); cytokine; alcoholic liver disease; CC-chemokine ligand 10; CC-chemokine ligand 5; dysbiosis; innate immunity

Funding

  1. National Institute on Alcohol Abuse and Alcoholism [R01AA027036, R21AA025841]
  2. NIDDK, National Institutes of Health [R01DK085252]
  3. American Liver Foundation Congressman John Joseph Moakley postdoctoral research fellowship
  4. National Research Foundation of Korea [2017R1C1B2004423]
  5. Cedars-Sinai Medical Center Winnick Research Award
  6. National Research Foundation of Korea [2017R1C1B2004423] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Excessive alcohol consumption induces intestinal dysbiosis of the gut microbiome and reduces gut epithelial integrity. This often leads to portal circulation-mediated translocation of gut-derived microbial products, such as lipopolysaccharide (LPS), to the liver, where these products engage Toll-like receptor 4 (TLR4) and initiate hepatic inflammation, which promotes alcoholic liver disease (ALD). Although the key self-destructive process of autophagy has been well-studied in hepatocytes, its role in macrophages during ALD pathogenesis remains elusive. Using WT and myeloid cell-specific autophagy-related 7 (Atg7) knockout (Atg7(Delta Mye)) mice, we found that chronic ethanol feeding for 6 weeks plus LPS injection enhances serum alanine aminotransferase and IL-1 beta levels and augments hepatic C-C motif chemokine ligand 5 (CCL5) and C-X-C motif chemokine ligand 10 (CXCL10) expression in WT mice, a phenotype that was further exacerbated in Atg7(Delta Mye) mice. Atg7(Delta Mye) macrophages exhibited defective mitochondrial respiration and displayed elevated mitochondrial reactive oxygen species production and inflammasome activation relative to WT cells. Interestingly, compared with WT cells, Atg7(Delta Mye) macrophages also had a drastically increased abundance and nuclear translocation of interferon regulatory factor 1 (IRF1) after LPS stimulation. Mechanistically, LPS induced co-localization of IRF1 with the autophagy adaptor p62 and the autophagosome, resulting in subsequent IRF1 degradation. However, upon p62 silencing or Atg7 deletion, IRF1 started to accumulate in autophagy-deficient macrophages and translocated into the nucleus, where it induced CCL5 and CXCL10 expression. In conclusion, macrophage autophagy protects against ALD by promoting IRF1 degradation and removal of damaged mitochondria, limiting macrophage activation and inflammation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22

Qinglan Wang, So Yeon Kim, Hiroshi Matsushita, Zhijun Wang, Vijay Pandyarajan, Michitaka Matsuda, Koichiro Ohashi, Takashi Tsuchiya, Yoon Seok Roh, Calvin Kiani, Yutong Zhao, Michael Chan, Suzanne Devkota, Shelly C. Lu, Tomoko Hayashi, Dennis A. Carson, Ekihiro Seki

Summary: TLR7 signaling has a protective effect in the AH mouse model, and the TLR7 agonistic agent 1Z1 holds therapeutic potential for the treatment of ALD. Oral administration of 1Z1 prevents intestinal barrier disruption and bacterial translocation, suppressing ethanol-induced hepatic injury, steatosis, and inflammation. 1Z1 treatment also up-regulates the expression of antimicrobial peptides and intestinal IL-22, modulating the microbiome composition and playing a protective role in the AH mouse model.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Editorial Material Cell Biology

Global Spread of a Local Fire Transmission of Endoplasmic Reticulum Stress via Connexin 43

Yoon Mee Yang, Ekihiro Seki

Summary: The study shows that intracellular ER stress can be transmitted to neighboring hepatocytes through connexin 43, leading to exacerbated ER stress and promoting hepatosteatosis and insulin resistance.

CELL METABOLISM (2021)

Article Oncology

Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations

Silvia Affo, Ajay Nair, Francesco Brundu, Aashreya Ravichandra, Sonakshi Bhattacharjee, Michitaka Matsuda, LiKang Chin, Aveline Filliol, Wen Wen, Xinhua Song, Aubrianna Decker, Jeremy Worley, Jorge Matias Caviglia, Lexing Yu, Deqi Yin, Yoshinobu Saito, Thomas Savage, Rebecca G. Wells, Matthias Mack, Lars Zender, Nicholas Arpaia, Helen E. Remotti, Raul Rabadan, Peter Sims, Anne-Laure Leblond, Achim Weber, Marc-Oliver Riener, Brent R. Stockwell, Jellert Gaublomme, Josep M. Llovet, Raghu Kalluri, George K. Michalopoulos, Ekihiro Seki, Daniela Sia, Xin Chen, Andrea Califano, Robert F. Schwabe

Summary: The study reveals that hepatic stellate cells (HSC) are the main source of cancer-associated fibroblasts (CAF), and HSC-derived CAF interact predominantly with tumor cells. In mouse models, CAF promote the progression of intrahepatic cholangiocarcinoma (ICC), while in patients, a high pan-CAF signature is associated with decreased survival and increased recurrence. Single-cell RNA sequencing segregates CAF into distinct subpopulations, with different interactions with tumor cells and promoting ICC growth.

CANCER CELL (2021)

Article Multidisciplinary Sciences

Depletion of mitochondrial methionine adenosyltransferase α1 triggers mitochondrial dysfunction in alcohol-associated liver disease

Lucia Barbier-Torres, Ben Murray, Jin Won Yang, Jiaohong Wang, Michitaka Matsuda, Aaron Robinson, Aleksandra Binek, Wei Fan, David Fernandez-Ramos, Fernando Lopitz-Otsoa, Maria Luque-Urbano, Oscar Millet, Nirmala Mavila, Hui Peng, Komal Ramani, Roberta Gottlieb, Zhaoli Sun, Suthat Liangpunsakul, Ekihiro Seki, Jennifer E. Van Eyk, Jose M. Mato, Shelly C. Lu

Summary: MAT alpha 1 plays a role in reducing activity and causing mitochondrial dysfunction in alcohol-associated liver disease (ALD). This study found that the peptidyl-prolyl cis/trans isomerase PIN1 and kinase CK2 mediate the selective depletion of mitochondrial MAT alpha 1 in ALD. Blocking the interaction between PIN1 and MAT alpha 1 increased mitochondrial levels of MAT alpha 1 and protected against alcohol-induced mitochondrial dysfunction and fat accumulation.

NATURE COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B

Guangyue Yang, Liping Zhuang, Tiantian Sun, Yee Hui Yeo, Le Tao, Wei Zhang, Wenting Ma, Liu Wu, Zongguo Yang, Yanqin Yang, Dongying Xue, Jie Zhang, Rilu Feng, Ebert P. Matthias, Steven Dooley, Ekihiro Seki, Ping Liu, Cheng Liu

Summary: By analyzing serum, tissue mRNA, and biopsy data, we found the potential of sGDNF as a novel noninvasive biomarker for predicting cirrhosis in chronic hepatitis B patients.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1

Le Tao, Guangyue Yang, Tiantian Sun, Jie Tao, Chan Zhu, Huimin Yu, Yalan Cheng, Zongguo Yang, Mingyi Xu, Yuefeng Jiang, Wei Zhang, Zhiyi Wang, Wenting Ma, Liu Wu, Dongying Xue, Dongxue Wang, Wentao Yang, Yongjuan Zhao, Shane Horsefield, Bostjan Kobe, Zhe Zhang, Zongxiang Tang, Qigen Li, Qiwei Zhai, Steven Dooley, Ekihiro Seki, Ping Liu, Jianrong Xu, Hongzhuan Chen, Cheng Liu

Summary: This study discovered the presence of TRPV1 in hepatic stellate cells (HSCs) and investigated its function in this cell type and liver fibrosis. TRPV1's expression is associated with liver fibrosis and its antifibrotic properties are attributed to the prevention of HSC activation. This finding could be a potential therapeutic strategy against liver fibrosis.

JOURNAL OF HEPATOLOGY (2023)

Editorial Material Gastroenterology & Hepatology

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis

Jieun Kim, Ekihiro Seki

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Cell Biology

Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment

Zhijun Wang, So Yeon Kim, Wei Tu, Jieun Kim, Alexander Xu, Yoon Mee Yang, Michitaka Matsuda, Lien Reolizo, Takashi Tsuchiya, Sandrine Billet, Alexandra Gangi, Mazen Noureddin, Ben A. Falk, Sungjin Kim, Wei Fan, Mourad Tighiouart, Sungyong You, Michael S. Lewis, Stephen J. Pandol, Dolores Di Vizio, Akil Merchant, Edwin M. Posadas, Neil A. Bhowmick, Shelly C. Lu, Ekihiro Seki

Summary: Liver metastasis is a major cause of death in colorectal cancer patients with fatty liver, but the underlying mechanism is unclear. Our study found that extracellular vesicles (EVs) derived from hepatocytes in fatty liver enhance the progression of CRC liver metastasis by promoting oncogenic Yes-associated protein (YAP) signaling and an immunosuppressive microenvironment. Fatty liver upregulates Rab27a expression, promoting EV production from hepatocytes. These EVs transfer YAP signaling-regulating microRNAs to cancer cells, augmenting YAP activity by suppressing LATS2.

CELL METABOLISM (2023)

Review Gastroenterology & Hepatology

In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations

Young-Sun Lee, Ekihiro Seki

Summary: It is crucial to choose an appropriate liver fibrosis model based on the purpose of study and type of disease due to the varied development and progression of liver fibrosis according to its etiology. This review provides a summary and analysis of various in vivo and in vitro liver fibrosis models and their implications and limitations. Liver fibrosis is a common consequence of various chronic liver diseases, and understanding its pathophysiology and identifying potential therapeutic targets is essential as it can progress to advanced liver diseases. Despite numerous studies, the underlying mechanisms of liver fibrosis remain unclear.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets

Jieun Kim, Ekihiro Seki

Summary: Hyaluronan plays a critical role in liver fibrosis by serving as both a key component of the extracellular matrix and a functional signaling molecule. Understanding the regulatory mechanisms of its synthesis and degradation, as well as its pathophysiological effects, is important for therapeutic intervention in liver fibrosis.

HEPATOLOGY COMMUNICATIONS (2023)

Meeting Abstract Gastroenterology & Hepatology

HEPATIC PROHIBITIN 1 AND METHIONINE ADENOSYLTRANSFERASE α1 DEFICIENCY SENSITIZES THE LIVER TO CANCER METASTASIS

Wei Fan, Jiaohong Wang, Tony Wh Li, Ting Liu, Jose M. Mato, Ekihiro Seki, Heping Yang, Shelly C. Lu

HEPATOLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

UBC13-MEDIATED P62 UBIQUITINATION PROTECTS AGAINST NON-ALCOHOLIC STEATOHEPATITIS LINKED TO DEFECT IN MITOPHAGY

Feng Wang, Yoon-Seok Roh, Jin Lee, Jeong-Su Park, So Yeon Kim, Yoon Mee Yang, Ekihiro Seki

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

GP130 PROMOTES THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA THROUGH INHIBITION OF BECLIN1-MEDIATED ABERRANT MITOPHAGY

Hwan Ma, Yoon-Seok Roh, Jin Lee, Jeong-Su Park, Feng Wang, Ekihiro Seki

GASTROENTEROLOGY (2022)

Article Biochemistry & Molecular Biology

Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4

Sun Myoung Kim, Ga Yeon Song, Aeri Shim, Jee Hyung Lee, Cheol Bin Eom, Cheng Liu, Yoon Mee Yang, Ekihiro Seki

Summary: Liver fibrosis is a disease characterized by excessive extracellular matrix deposition during wound healing after repeated liver injury. Recent research has identified hyaluronan synthase 2 (HAS2) as a driver of liver fibrosis and hepatic stellate cell (HSC) activation. This study reveals that miR-200c negatively regulates HAS2 and contributes to the development of acute liver injury and chronic liver inflammation. Additionally, hyaluronidase-2 (HYAL2) is found to be overexpressed in fibrotic livers, which indicates its potential involvement in liver fibrosis.

EXPERIMENTAL AND MOLECULAR MEDICINE (2022)

Article Gastroenterology & Hepatology

Hepatocyte TGF-β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let-7b-5p

Jinfang Zhao, Lilin Hu, Wenfang Gui, Li Xiao, Weijun Wang, Jing Xia, Huiqian Fan, Zhonglin Li, Qingjing Zhu, Xiaohua Hou, Huikuan Chu, Ekihiro Seki, Ling Yang

Summary: TGF-beta signaling in hepatocytes promotes steatosis and body weight gain, and its specific role in NAFLD is not fully understood. The study found that hepatocyte TGF-beta signaling can promote obesity and fatty liver induced by a high-fat diet by regulating mitochondrial oxidative phosphorylation and suppressing white-to-beige fat conversion. It was also found that let-7b-5p derived from hepatocyte-secreted exosomes plays an important role in this process.

HEPATOLOGY COMMUNICATIONS (2022)

No Data Available